ReviewJournal of the Pediatric Orthopaedic Society of North America2023
FDA Device Approval-What You Were Not Taught in Training.
Review in Journal of the Pediatric Orthopaedic Society of North America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Orphan medical devices: addressing the regulatory and access gaps in the EU and US.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical devices are ubiquitous in the practice of pediatric orthopaedic surgery, but few surgeons receive any formal training or education on the process of bringing a medical device to market for pediatric orthopaedic patients. Innovation in the field of medical devices has led to significant improvement in the care of pediatric orthopaedic patients. The American Academy of Orthopaedic Surgeons (AAOS) and the Pediatric Orthopaedic Society of North America (POSNA) recognize the importance of making innovative medical devices available to pediatric patients and have made advocacy an important aspect of their mission and relationship with industry and governmental regulatory organizations. Understanding the history, structure, and pathways to market approval are critical to encouraging the innovation of novel devices and techniques and improving the care of pediatric orthopaedic patients. Orthopaedists should have a command of the concepts of adverse event reporting as well as an understanding of the on- and off-label uses of medical devices as this is helpful for discussion of care and informed consent for the use of such devices. Due to the relative rarity of the diseases addressed, pediatric orthopaedists should understand the framework of the humanitarian device exemption as well. These concepts can be synergized into some successful improvements in care for pediatric orthopaedic patients. One such success story in recent history was the introduction of the Vertical Expandable Titanium Prosthetic Rib (VEPTR) system by Dr. Robert Campell Jr.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.